The Full Wiki

Tachykinin receptor 1: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Tachykinin receptor 1
Identifiers
Symbols TACR1; SPR; NK1R; NKIR; TAC1R
External IDs OMIM162323 MGI98475 HomoloGene20288 IUPHAR: NK1 GeneCards: TACR1 Gene
RNA expression pattern
PBB GE TACR1 208049 s at tn.png
PBB GE TACR1 210637 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 6869 21336
Ensembl ENSG00000115353 ENSMUSG00000030043
UniProt P25103 Q3V353
RefSeq (mRNA) NM_001058 NM_009313
RefSeq (protein) NP_001049 NP_033339
Location (UCSC) Chr 2:
75.13 - 75.28 Mb
Chr 6:
82.37 - 82.53 Mb
PubMed search [1] [2]

The tachykinin receptor 1 (TACR1) also known as neurokinin 1 receptor (NK1R) or substance P receptor (SPR) is a G protein coupled receptor found in the central nervous system and peripheral nervous system. The endogenous ligand for this receptor is Substance P, although it has some affinity for other tachykinins. The protein is the product of the TACR1 gene.[1]

Contents

Clinical significance

This receptor is considered an attractive drug target, particularly with regards to potential analgesics and anti-depressants.[2][3] It was identified as a candidate in the etiology of bipolar disorder by a 2008 study.[4] Furthermore TACR1 antagonists have shown promise for the treatment in alcoholism.[5] Finally TACR1 antagonists may also have a role as novel antiemetics.[6]

Selective ligands

Many selective ligands for NK1 are now available, several of which have gone into clinical use as antiemetics.

Advertisements

Agonists

  • GR-73632 - potent and selective agonist, EC50 2nM, 5-amino acid polypeptide chain. CAS# 133156-06-6

Antagonists

  • Aprepitant
  • Casopitant
  • Ezlopitant
  • Fosaprepitant
  • Lanepitant
  • Maropitant
  • Vestipitant
  • L-733,060
  • L-741,671
  • L-742,694
  • RP-67580 - potent and selective antagonist, Ki 2.9nM, (3aR,7aR)-Octahydro-2-[1-imino-2-(2-methoxyphenyl)ethyl ]-7,7-diphenyl-4H-isoindol, CAS# 135911-02-3
  • RPR-100,893
  • CP-96345
  • CP-99994
  • GR-205,171
  • TAK-637
  • T-2328

See also

References

  1. ^ Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE (1991). "Molecular cloning, structural characterization and functional expression of the human substance P receptor". Biochem. Biophys. Res. Commun. 179 (3): 1232–40. doi:10.1016/0006-291X(91)91704-G. PMID 1718267.  
  2. ^ Humphrey JM (2003). "Medicinal chemistry of selective neurokinin-1 antagonists". Current topics in medicinal chemistry 3 (12): 1423–35. doi:10.2174/1568026033451925. PMID 12871173.  
  3. ^ Yu YJ, Arttamangkul S, Evans CJ, Williams JT, von Zastrow M (January 2009). "Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons". The Journal of Neuroscience : the Official Journal of the Society for Neuroscience 29 (1): 222–33. doi:10.1523/JNEUROSCI.4315-08.2009. PMID 19129399.  
  4. ^ Perlis RH, Purcell S, Fagerness J, Kirby A, Petryshen TL, Fan J, Sklar P (January 2008). "Family-based association study of lithium-related and other candidate genes in bipolar disorder". Arch. Gen. Psychiatry 65 (1): 53–61. doi:10.1001/archgenpsychiatry.2007.15. PMID 18180429.  
  5. ^ George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M (March 2008). "Neurokinin 1 receptor antagonism as a possible therapy for alcoholism". Science (journal) 319 (5869): 1536–9. doi:10.1126/science.1153813. PMID 18276852.  
  6. ^ Jordan K (2006). "Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy". Onkologie 29 (1-2): 39–43. doi:10.1159/000089800. PMID 16514255.  

Further reading

  • Burcher E (1989). "The study of tachykinin receptors.". Clin. Exp. Pharmacol. Physiol. 16 (6): 539–43. doi:10.1111/j.1440-1681.1989.tb01602.x. PMID 2548782.  
  • Kowall NW, Quigley BJ, Krause JE, et al. (1993). "Substance P and substance P receptor histochemistry in human neurodegenerative diseases.". Regul. Pept. 46 (1-2): 174–85. doi:10.1016/0167-0115(93)90028-7. PMID 7692486.  
  • Patacchini R, Maggi CA (2002). "Peripheral tachykinin receptors as targets for new drugs.". Eur. J. Pharmacol. 429 (1-3): 13–21. doi:10.1016/S0014-2999(01)01301-2. PMID 11698023.  
  • Saito R, Takano Y, Kamiya HO (2003). "Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.". J. Pharmacol. Sci. 91 (2): 87–94. doi:10.1254/jphs.91.87. PMID 12686752.  
  • Fong TM, Yu H, Huang RR, Strader CD (1992). "The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides.". Biochemistry 31 (47): 11806–11. doi:10.1021/bi00162a019. PMID 1280161.  
  • Fong TM, Huang RR, Strader CD (1993). "Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.". J. Biol. Chem. 267 (36): 25664–7. PMID 1281469.  
  • Fong TM, Anderson SA, Yu H, et al. (1992). "Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.". Mol. Pharmacol. 41 (1): 24–30. PMID 1310144.  
  • Takahashi K, Tanaka A, Hara M, Nakanishi S (1992). "The primary structure and gene organization of human substance P and neuromedin K receptors.". Eur. J. Biochem. 204 (3): 1025–33. doi:10.1111/j.1432-1033.1992.tb16724.x. PMID 1312928.  
  • Walsh DA, Mapp PI, Wharton J, et al. (1992). "Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis.". Ann. Rheum. Dis. 51 (3): 313–7. doi:10.1136/ard.51.3.313. PMID 1374227.  
  • Gerard NP, Garraway LA, Eddy RL, et al. (1991). "Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones.". Biochemistry 30 (44): 10640–6. doi:10.1021/bi00108a006. PMID 1657150.  
  • Hopkins B, Powell SJ, Danks P, et al. (1991). "Isolation and characterisation of the human lung NK-1 receptor cDNA.". Biochem. Biophys. Res. Commun. 180 (2): 1110–7. doi:10.1016/S0006-291X(05)81181-7. PMID 1659396.  
  • Takeda Y, Chou KB, Takeda J, et al. (1991). "Molecular cloning, structural characterization and functional expression of the human substance P receptor.". Biochem. Biophys. Res. Commun. 179 (3): 1232–40. doi:10.1016/0006-291X(91)91704-G. PMID 1718267.  
  • Giuliani S, Barbanti G, Turini D, et al. (1992). "NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.". Eur. J. Pharmacol. 203 (3): 365–70. doi:10.1016/0014-2999(91)90892-T. PMID 1723045.  
  • Ichinose H, Katoh S, Sueoka T, et al. (1991). "Cloning and sequencing of cDNA encoding human sepiapterin reductase--an enzyme involved in tetrahydrobiopterin biosynthesis.". Biochem. Biophys. Res. Commun. 179 (1): 183–9. doi:10.1016/0006-291X(91)91352-D. PMID 1883349.  
  • Thöny B, Heizmann CW, Mattei MG (1995). "Human GTP-cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hybridization.". Genomics 26 (1): 168–70. doi:10.1016/0888-7543(95)80101-Q. PMID 7782081.  
  • Fong TM, Cascieri MA, Yu H, et al. (1993). "Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345.". Nature 362 (6418): 350–3. doi:10.1038/362350a0. PMID 8384323.  
  • Derocq JM, Ségui M, Blazy C, et al. (1997). "Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.". FEBS Lett. 399 (3): 321–5. doi:10.1016/S0014-5793(96)01346-4. PMID 8985172.  
  • De Felipe C, Herrero JF, O'Brien JA, et al. (1998). "Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.". Nature 392 (6674): 394–7. doi:10.1038/32904. PMID 9537323.  

External links


Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message